PROCAINAMIDE HYDROC and 1 more item

Defense Logistics Agency Troop Support Medical Supply Chain is soliciting quotes under RFQ SPE2DP26T5314 for Procainamide Hydrochloride Injection (NSN 6505-01-240-8703), with quotes due October 8, 2026. The acquisition carries no set-aside: the notice reads "No Set-Aside Used." The solicitation is a Fast Auto Evaluation, and the acquisition may be eligible for automated award unless first article test requirements apply. Quotes must be submitted through DIBBS.

Two line items each call for 2 packages, delivered within 5 days on FOB Destination terms with inspection and acceptance at destination. The notice requests no quoted pricing in the RFQ document itself. The PSC is 6505, Drugs and Biologicals.

The attachment summary, which is derived and not authoritative, reports that each package contains 25 units of 100 mg/mL, 10 mL vials and must have a 24-month shelf life with at least 21 months remaining from manufacture to delivery. It names Pfizer Inc, part number NDC 00409-1902-01, and requires packaging and marking to Medical Marking Standard No. 1 and MIL-STD-2073-1E. The same summary lists the incorporated DLA Master Solicitation for Automated Simplified Acquisitions Revision 105, with clauses covering hazardous material handling, Buy American compliance, sea transportation, and WAWF payment submission. It also reports prior awards to CAGE 00E55 ranging from $174.89 to $1,605.15 per package, with the most recent around $1,513.54.